Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on Staidson Beijing Biopharma's Revenue:
We've identified the following companies as similar to Staidson Beijing Biopharma because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Revenue in the popular category include:
The revenue metric captures the total income generated by a company from its core operational activities
Staidson BioPharmaceuticals reported revenue of 350.7 M for the latest twelve months ending September 30, 2024 on its income statement.
The tables below summarises Staidson BioPharmaceuticals’s Revenue over the last five years:
| Fiscal Year | Revenue |
|---|---|
| 2019-12-31 | 661.5 M |
| 2020-12-31 | 425.2 M |
| 2021-12-31 | 584.3 M |
| 2023-01-01 | 549 M |
| 2023-12-31 | 364.2 M |
The tables below summarizes Staidson BioPharmaceuticals’s Revenue over the last four quarters:
| Quarter Ending | Revenue |
|---|---|
| 2023-12-31 | 89.724 M |
| 2024-03-31 | 94.983 M |
| 2024-06-30 | 87.406 M |
| 2024-09-30 | 78.598 M |
The chart above depicts the distribution of Revenue for companies operating in the Healthcare Sector in the Developing economic region. Over 1,180 companies were considered in this analysis, and 1,133 had meaningful values. The average Revenue of companies in the Sector is 2.135 B with a standard deviation of 3.889 B. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Staidson Beijing Biopharma's Revenue of 350.7 M ranks in the 33.4% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developing |
| Total Constituents | 1,181 |
| Included Constituents | 1,133 |
| Min | 3.759 M |
| Max | 27.516 B |
| Median | 701 M |
| Mean | 2.135 B |
| Standard Deviation | 3.889 B |
You can find companies with similar Revenue using this stock screener.